GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » REMSleep Holdings Inc (OTCPK:RMSL) » Definitions » Days Sales Outstanding

REMSleep Holdings (REMSleep Holdings) Days Sales Outstanding : 325.89 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is REMSleep Holdings Days Sales Outstanding?

REMSleep Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $0.03 Mil. REMSleep Holdings's Revenue for the three months ended in Dec. 2023 was $0.01 Mil. Hence, REMSleep Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 325.89.

The historical rank and industry rank for REMSleep Holdings's Days Sales Outstanding or its related term are showing as below:

RMSL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 13.64   Med: 16.22   Max: 45.8
Current: 45.8

During the past 13 years, REMSleep Holdings's highest Days Sales Outstanding was 45.80. The lowest was 13.64. And the median was 16.22.

RMSL's Days Sales Outstanding is ranked better than
75.96% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.66 vs RMSL: 45.80

REMSleep Holdings's Days Sales Outstanding increased from Dec. 2022 (19.55) to Dec. 2023 (325.89).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


REMSleep Holdings Days Sales Outstanding Historical Data

The historical data trend for REMSleep Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

REMSleep Holdings Days Sales Outstanding Chart

REMSleep Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 13.64 18.79

REMSleep Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.55 14.32 51.04 80.72 325.89

Competitive Comparison of REMSleep Holdings's Days Sales Outstanding

For the Medical Devices subindustry, REMSleep Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


REMSleep Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, REMSleep Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where REMSleep Holdings's Days Sales Outstanding falls into.



REMSleep Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

REMSleep Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.012 + 0.009) / 2 ) / 0.204*365
=0.0105 / 0.204*365
=18.79

REMSleep Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.041 + 0.009) / 2 ) / 0.007*365 / 4
=0.025 / 0.007*365 / 4
=325.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


REMSleep Holdings  (OTCPK:RMSL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


REMSleep Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of REMSleep Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


REMSleep Holdings (REMSleep Holdings) Business Description

Traded in Other Exchanges
N/A
Address
14175 ICOT Blvd, Suite 300, Clearwater, FL, USA, 33760
REMSleep Holdings Inc is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. The company offers the product DeltaWave which is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Geographically, the business activity of the group functions through the region of the United States.
Executives
Russell Finlay Bird 10 percent owner, officer: President 722 50TH STREET, DES MOINES IA 50312
Tom J Wood director, officer: CEO 1170 CHERRYWOOD RD, WAYCROSS GA 31503
Thomas Brookes director, officer: VP & MD OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN 5G2
Matthew Sullivan director, officer: ASST. VP OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN5G2
David M Barnes officer: Chief Financial Officer 6800 JERICHO TURNPIKE, SUITE 208E, SYOSSET NY 11791
Walter Leslie Thistle director, other: Chairman of the Board 17 COLLINGWOOD CRESCENT, MOUNT PEARL A4 A1N5C6
Kat Exploration Inc. 10 percent owner 1149 TOPSAIL ROAD, MOUNT PEARL A4 A1N5G2
Ken Stead director, 10 percent owner, officer: CEO and President 15 BLADE CRESCENT, MOUNT PEARL A4 A1N 5L1
Ronald Davis officer: PRESIDENT 4412 8TH STREET SW, VERO BEACH FL 32968

REMSleep Holdings (REMSleep Holdings) Headlines

From GuruFocus

Shareholder Update

By Marketwired Marketwired 11-19-2020

REMSleep 510K

By Marketwired Marketwired 06-02-2021

Deltawave CPAP Interface Mask

By Marketwired Marketwired 07-06-2021

REMSleep 510K Submission

By Marketwired Marketwired 10-28-2021

REMSleep 510K Submission

By Marketwired Marketwired 07-15-2021

REMSleep Patent Application

By Marketwired Marketwired 11-20-2020